E Fund Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Buy |
17,184
+2,197
| +15% | +$30.8K | 0.01% | 340 |
|
|
2025
Q1 | $234K | Buy |
14,987
+108
| +0.7% | +$1.69K | 0.01% | 347 |
|
|
2024
Q4 | $207K | Sell |
14,879
-2,906
| -16% | -$40.5K | 0.01% | 358 |
|
|
2024
Q3 | $165K | Buy |
17,785
+2,026
| +13% | +$18.8K | 0.01% | 337 |
|
|
2024
Q2 | $147K | Sell |
15,759
-23,107
| -59% | -$215K | 0.01% | 302 |
|
|
2024
Q1 | $385K | Buy |
+38,866
| New | +$385K | 0.02% | 231 |
|
|
2023
Q4 | – | Sell |
-21,535
| Closed | -$114K | – | 310 |
|
|
2023
Q3 | $114K | Sell |
21,535
-5,342
| -20% | -$28.3K | 0.01% | 278 |
|
|
2023
Q2 | $256K | Buy |
26,877
+9,578
| +55% | +$91.2K | 0.02% | 238 |
|
|
2023
Q1 | $190K | Buy |
17,299
+1,419
| +9% | +$15.6K | 0.01% | 306 |
|
|
2022
Q4 | $235K | Buy |
15,880
+3,933
| +33% | +$58.2K | 0.02% | 272 |
|
|
2022
Q3 | $228K | Buy |
+11,947
| New | +$228K | 0.02% | 279 |
|